DIACCURATE acquires BIOKINESIS to create a sole-in-class biotech player in oncology and immunotherapy BIOKINESIS absorption by DIACCURATE occurred early December 2020Dr. Dominique BRIDON leads the new entityDIACCURATE is now developing 3 programs in cancer and immunotherapyDIACCURATE will be...